TY - JOUR
T1 - Interactions between effecters linked to serotonin receptors
AU - Berg, K. A.
AU - Maayani, S.
AU - Clarke, W. P.
PY - 1998
Y1 - 1998
N2 - In general, there are two types of interactions between effector signaling pathways. 'Homologous' interactions are those that occur within a receptor system to alter its own responsiveness, for example the loss of responsiveness (desensitization) that can occur upon agonist occupancy of a receptor. 'Heterologous' interactions are those that occur between different receptor systems where the responsiveness of one receptor system is regulated (positively or negatively) by activation of another receptor system (i.e., 'cross-talk'), Many, if not all receptors, couple to multiple cellular effector pathways and alterations in the responsiveness of a receptor system can be effector pathway-dependent which underscores the importance of studying each effector coupled to a receptor. Regulation of receptor system responsiveness, and consequently the efficacy of drugs, is a highly dynamic process. Perhaps by exploiting these interactions, new targets for pharmacotherapy may be uncovered which will provide for increased efficacy and specificity of drug action.
AB - In general, there are two types of interactions between effector signaling pathways. 'Homologous' interactions are those that occur within a receptor system to alter its own responsiveness, for example the loss of responsiveness (desensitization) that can occur upon agonist occupancy of a receptor. 'Heterologous' interactions are those that occur between different receptor systems where the responsiveness of one receptor system is regulated (positively or negatively) by activation of another receptor system (i.e., 'cross-talk'), Many, if not all receptors, couple to multiple cellular effector pathways and alterations in the responsiveness of a receptor system can be effector pathway-dependent which underscores the importance of studying each effector coupled to a receptor. Regulation of receptor system responsiveness, and consequently the efficacy of drugs, is a highly dynamic process. Perhaps by exploiting these interactions, new targets for pharmacotherapy may be uncovered which will provide for increased efficacy and specificity of drug action.
UR - http://www.scopus.com/inward/record.url?scp=0032534297&partnerID=8YFLogxK
U2 - 10.1111/j.1749-6632.1998.tb10181.x
DO - 10.1111/j.1749-6632.1998.tb10181.x
M3 - Article
C2 - 9928247
AN - SCOPUS:0032534297
SN - 0077-8923
VL - 861
SP - 111
EP - 120
JO - Annals of the New York Academy of Sciences
JF - Annals of the New York Academy of Sciences
ER -